Self-report and urine drug screen concordance among women with co-occurring PTSD and substance use disorders participating in a clinical trial: Impact of drug type and participant characteristics
- PMID: 36696843
- PMCID: PMC9987239
- DOI: 10.1016/j.drugalcdep.2023.109769
Self-report and urine drug screen concordance among women with co-occurring PTSD and substance use disorders participating in a clinical trial: Impact of drug type and participant characteristics
Abstract
Background: Self-report measures are important in substance use assessment, yet they are susceptible to reporting errors. Urine drug screens (UDS) are often considered a more valid alternative. However, collecting in-person UDS may not always be feasible, contributing to the need to understand factors that influence the validity of self-reported substance use.
Methods: In this secondary analysis of data from 295 women with co-occurring PTSD and substance use disorders (SUD) who participated in a clinical trial testing behavioral interventions, we examined concordance and discordance between self-reported drug use and associated UDS results. Generalized linear mixed models were used to examine the impact of treatment type and participant characteristics on the associations between self-reported drug use and UDS results.
Results: Findings revealed higher disagreement between self-report and UDS for opioids and sedatives (ranging from.77 to.90) and lower disagreement rates for cannabis and cocaine (ranging from.26 to.33). Treatment type was not a significant moderator of the associations between self-report and UDS across all drugs. Among those with a positive opioid UDS, those who reported employment in the past three years were more likely to self-report no opioid use compared to their counterparts without employment in the past three years.
Conclusions: Findings add to the literature that supports the validity of self-reported cannabis and cocaine use. The greater discrepancies between self-report and UDS test results of opioids and sedatives suggest adjunctive UDS may be required, although a variety of factors other than inaccurate self-report may be associated with this discrepancy.
Trial registration: ClinicalTrials.gov NCT00078156.
Keywords: PTSD; Self-report; Substance use disorder; Treatment; Urine drug screen; Women.
Copyright © 2023 Elsevier B.V. All rights reserved.
Conflict of interest statement
Declaration of Competing Interest None.
Figures
Similar articles
-
High on drugs: Multi-institutional pilot study examining the effects of substance use on acute pain management.Injury. 2019 May;50(5):1058-1063. doi: 10.1016/j.injury.2019.01.003. Epub 2019 Jan 8. Injury. 2019. PMID: 30642622
-
Characteristics of women concordant and discordant for urine drug screens for cannabis exposure and self-reported cannabis use during pregnancy.Neurotoxicol Teratol. 2024 May-Jun;103:107351. doi: 10.1016/j.ntt.2024.107351. Epub 2024 Apr 10. Neurotoxicol Teratol. 2024. PMID: 38604316 Free PMC article.
-
Interpersonal Violence, PTSD, and Substance Use Types among Women Receiving Substance Use Treatment.J Dual Diagn. 2022 Jul-Sep;18(3):123-134. doi: 10.1080/15504263.2022.2090649. Epub 2022 Jul 8. J Dual Diagn. 2022. PMID: 35802744 Free PMC article.
-
Substance Abuse Risk and Medication Monitoring in Patients with Advanced Lung Cancer Receiving Palliative Care.J Pain Palliat Care Pharmacother. 2021 Jun;35(2):91-99. doi: 10.1080/15360288.2021.1920545. Epub 2021 May 19. J Pain Palliat Care Pharmacother. 2021. PMID: 34010103 Review.
-
Validity of self-report measures of cannabis use compared to biological samples among women of reproductive age: a scoping review.BMC Pregnancy Childbirth. 2022 Apr 21;22(1):344. doi: 10.1186/s12884-022-04677-0. BMC Pregnancy Childbirth. 2022. PMID: 35448967 Free PMC article.
Cited by
-
Urine toxicology screening reduces misdiagnosis of cocaine-induced ANCA-positive disease as idiopathic granulomatosis with polyangiitis.Rheumatol Adv Pract. 2025 Feb 11;9(2):rkaf018. doi: 10.1093/rap/rkaf018. eCollection 2025. Rheumatol Adv Pract. 2025. PMID: 40225232 Free PMC article.
-
Do Postoperative Orthopedic Patients Accurately Report Their Narcotic Medication Usage Using the Interventional Pain Assessment Drugs Scale?Cureus. 2025 Jun 12;17(6):e85852. doi: 10.7759/cureus.85852. eCollection 2025 Jun. Cureus. 2025. PMID: 40656340 Free PMC article.
-
Cannabis legalization and increasing cannabis use in the United States: Data from urine toxicology testing in emergency room patients.Int J Drug Policy. 2025 Apr;138:104765. doi: 10.1016/j.drugpo.2025.104765. Epub 2025 Mar 8. Int J Drug Policy. 2025. PMID: 40058102
-
Protocol of a randomized controlled trial examining psychosocial enhancement and standard medication treatment for co-occurring opioid use and mental health disorders: A half fractional factorial randomized controlled trial.Contemp Clin Trials. 2024 Oct;145:107668. doi: 10.1016/j.cct.2024.107668. Epub 2024 Aug 18. Contemp Clin Trials. 2024. PMID: 39163904
-
The Concordance of Electronic Health Record Diagnoses and Substance use Self-Reports Among Reproductive Aged Women Enrolled in a Community-Based Addiction Reduction Program.Inquiry. 2024 Jan-Dec;61:469580241237051. doi: 10.1177/00469580241237051. Inquiry. 2024. PMID: 38528783 Free PMC article.
References
-
- Abraham A, & Luty J. (2010). Testing for illicit drug use in mental health services. Advances in Psychiatric Treatment, 16(5), 369–379. 10.1192/apt.bp.108.005835 - DOI
-
- Basurto FZ, Montes JMG, Cubos PF, Santed FS, Ríos FL, & Moreno AM (2009). Validity of the self-report on drug use by university students: correspondence between self-reported use and use detected in urine. Psicothema, 213–219. - PubMed
-
- Buchan BJ, Dennis ML, Tims FM, & Diamond GS (2002). Cannabis use: consistency and validity of self-report, on-site urine testing and laboratory testing. Addiction, 97, 98–108. - PubMed